Vizient Experts on Quality Improvement in Health Care to Present at IHI National Forum

IRVING, Texas--(BUSINESS WIRE)--In a health care landscape that is constantly changing, making and sustaining quality improvements in patient safety and care can be challenging. Vizient understands these challenges and its experts in safety and quality will be presenting improvement strategies at the IHI National Forum being held Dec. 9-12 in Orlando. In addition to being a sponsor for the event, patient safety and quality improvement More

Vizient Collaboration with MedShorts Enables Members to Save on Drug Costs

IRVING, Texas--(BUSINESS WIRE)--In June 2017, Vizient began collaborating with the independent software company MedShorts to develop a first-to-market platform that allows pharmaceutical manufacturers to channel their surplus inventory directly to hospital pharmacies. Since that time, over 300,000 units of medication have been successfully matched and connected to hospital pharmacies with immediate patient needs, at reduced costs, mitigating obsolete More

Vizient Employees Complete 8,000 Hours of Community Service during Annual Event

IRVING, Texas--(BUSINESS WIRE)--Employees from Vizient, Inc. completed 8000 hours of community service hours as part of the company’s 16th annual Community Day event held on Oct. 16. The event included 75 sites, in 42 cities in 19 states. Included in this year’s 75 sites were food banks, city parks and homeless shelters as well as projects serving children and adults with special needs. Volunteers also assisted in Florida with ongoing More

Vizient Recognizes 18 Children’s Hospitals for Performance Achievements in 2018

IRVING, Texas--(BUSINESS WIRE)--Vizient, Inc. today announced the winners of its supply chain program awards for participating Children’s Hospital Association (CHA) members. The awards, which recognize the outstanding performance in six categories, were presented at CHA’s Improving Performance Conference, held Oct. 4 in Glendale, Ariz. “Our supply chain program for our CHA members offer benefits beyond cost savings and rebates. They More

The Pharmacy Module is the Newest Addition to the Vizient Savings Actualyzer Platform

IRVING, Texas--(BUSINESS WIRE)--With pharmaceuticals comprising up to 40 percent of a hospital’s supply spend, and drug price projections predicting a 5-percent increase in 2019 alone, hospital pharmacy teams need analytics to help them better manage spend and identify cost-savings opportunities across their health system. To address this need, Vizient announces it has added a pharmacy module to its Savings Actualyzer platform. “The new More

Application Deadline Approaches for the Vizient Spring 2019 Innovative Technology Exchange

IRVING, Texas--(BUSINESS WIRE)--Suppliers interested in showcasing their innovative technology to decision makers from hospitals from across the country are encouraged to submit their application now to participate in the 2019 Vizient Innovative Technology Exchange. The event, which is part of Vizient’s Spring Connections Summit, will take place on Thursday, April 4, 2019, at the Aria in Las Vegas. The deadline to apply to participate in the More

Vizient, Inc. Disappointed as CMS Finalizes 340B & “Site-Neutral” Policies in Final OPPS Rule

IRVING, Texas--(BUSINESS WIRE)--Vizient, Inc. is disappointed that the Centers for Medicare and Medicaid Services (CMS) opted to finalize site-neutral payment reductions and the expansion of payment cuts related to the 340B Drug Pricing Program in the final 2019 Outpatient Prospective Payment System (OPPS) rule. The continuation of these damaging cuts will impact hospitals’ ability to maintain and expand access to care in rural and underserved More

Vizient Applauds FDA Approval of Biosimilar UDENYCA

IRVING, Texas--(BUSINESS WIRE)--Vizient announces its support for the approval of UDENYCA™ (pegfilgrastim-cbqv), the second pegfilgrastim biosimilar approved by the Food and Drug Administration (FDA) and the first to be authorized by both the U.S. and the European Commission for patients with cancer receiving myelosuppressive chemotherapy. UDENYCA is the first drug from Coherus BioSciences, Inc. (NASDAQ: CHRS) to receive FDA or EC approval More

Vizient and Provista Urge CMS to Reconsider Approach to Medicare Home Infusion Benefits

IRVING, Texas--(BUSINESS WIRE)--Vizient, the largest member-driven health care performance improvement company in the country and its subsidiary Provista, a leading supply chain partner for non-acute health care delivery organizations, urge CMS to reconsider its approach to the Medicare home infusion therapy benefit to recognize the full array of services needed for home infusion therapy services. Yesterday afternoon CMS finalized a very More

Vizient Supports HHS Proposal to Implement Long-Stalled 340B Rule

IRVING, Texas--(BUSINESS WIRE)--Vizient announces its strong support for the Department of Health and Human Services’ (HHS) proposed rule to implement a 340B Drug Pricing Program regulation that would refine calculations establishing the 340B ceiling price and apply penalties for drug manufacturers that knowingly overcharge hospitals for drugs purchased through the program. The proposed rule would move the effective date to Jan. 1, 2019 More